Goodwin advised Codiak BioSciences on the deal Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the closing of a Series C financing round of…
Codiak BioSciences’ $76.5 Million Series C Financing

Goodwin advised Codiak BioSciences on the deal Codiak BioSciences, Inc., the leading exosome therapeutics company, today announced the closing of a Series C financing round of…
You must be a Standard 1 Year member to access this content.
…
You must be a Standard 1 Year member to access this content.